Cite
APA Citation
Piha-Paul, S., Oh, D., Garralda, E., Vieito, M., Huang, J., Kirschbaum, M., & Villanona-Calero, M. (n.d.). a phase 1/2, open-label, multicenter study to investigate the safety, pharmacokinetics, and efficacy of fadraciclib (CYC065), an oral CDK2/9 inhibitor, in subjects with advanced solid tumors and lymphoma. European journal of cancer, 174, S17–S18. http://access.bl.uk/ark:/81055/vdc_100169168656.0x000039